Zobrazeno 1 - 10
of 136
pro vyhledávání: '"Anthony G Catto-Smith"'
Autor:
Asha Jois, Diana Zannino, Anthony G Catto‐Smith, Meg Kaegi, Jonathan P Mynard, Jeremy Rosenbaum, Mark Oliver, Winita Hardikar, George Alex, David Burgner
Publikováno v:
JGH Open, Vol 8, Iss 6, Pp n/a-n/a (2024)
Abstract Background and Aim People with inflammatory bowel disease (IBD) have an increased risk of cardiovascular disease, including in younger adulthood. This may arise in part from chronic, systemic low‐grade inflammation. The process of atherosc
Externí odkaz:
https://doaj.org/article/cf81d9cf3f2848a991d05f5056e35392
Autor:
Josef Wagner, Winnie H Sim, Justine A Ellis, Eng K Ong, Anthony G Catto-Smith, Donald J S Cameron, Ruth F Bishop, Carl D Kirkwood
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e15376 (2010)
Genetic susceptibility is an important contributor to the pathogenesis of Crohn's disease (CD). We investigated multiple CD susceptibility genes in an Australian paediatric onset CD cohort. Newly diagnosed paediatric onset CD patients (n = 72) and co
Externí odkaz:
https://doaj.org/article/f723c790260d47eea0b1f4364aaa33b3
Autor:
Josef Wagner, Kirsty Short, Anthony G Catto-Smith, Don J S Cameron, Ruth F Bishop, Carl D Kirkwood
Publikováno v:
PLoS ONE, Vol 3, Iss 10, p e3578 (2008)
Molecular analysis of bacterial 16S rRNA genes has made a significant contribution to the identification and characterisation of bacterial flora in the human gut. In particular, this methodology has helped characterise bacterial families implicated i
Externí odkaz:
https://doaj.org/article/a1908c8989e044138fa51b6cc485027d
Publikováno v:
Journal of Paediatrics and Child Health. 56:1769-1773
Aim To determine the nature and extent of interactions between retail pharmacists and families of infants concerned about functional gastrointestinal disorders. Methods A 15-question online survey was developed that could be completed by retail pharm
Autor:
Julie A. Jordan-Ely, Bridget R. Southwell, Anthony Lamanna, John M. Hutson, Anthony G. Catto-Smith, Siavash Foroughi, Kaic Fiuza, Suzanna Vidmar, Lauren D. Dughetti, Louise M P Kooiman, Megan Dynan, Naomi Murakami, Adeline Foo, Kyla M. Dobson, Marcelo C. Leal
Publikováno v:
JGH Open. 2:144-151
Background and Aim: Polyethylene glycol (PEG) is the gold standard for fecal disimpaction in constipation. A regimen of PEG combined with the stimulant laxative sodium picosulphate (SPS) produced fecal disimpaction in chronically constipated children
Autor:
Mark R. Oliver, Winita Hardikar, Anell Meyer, Anthony G. Catto-Smith, Di Simpson, Joe Crameri, Donald J. S. Cameron, George Alex
Publikováno v:
Journal of Gastroenterology and Hepatology. 32:395-400
Background Oesophageal achalasia is well-recognized but relatively rare in children, occasionally appearing as the “triple A” syndrome (with adrenal insufficiency and alacrima). Treatment modalities, as in adult practice, are not curative, often
Autor:
Josef Wagner, Carl D. Kirkwood, Sarah Thomas, Anthony G. Catto-Smith, Mark R. Oliver, George Alex, Shivani Kansal, Donald J. S. Cameron, Karen Boniface
Publikováno v:
Journal of Crohn'scolitis. 13(8)
Background and AimsThe gut mucosa is the principal site where Crohn’s disease [CD] inflammation occurs. Limited information is available about the gut mucosal microbiome during CD relapse and remission. The aim of our study was to characterize spec
Autor:
Thomas Ludwig, Yvan Vandenplas, Hania Szajewska, Suporn Treepongkaruna, Annamaria Staiano, Abdelhak Abkari, Sylvia Cruchet, Neil Shah, Silvia Salvatore, Badriul Hegar, Wei Cai, Frédéric Gottrand, Anthony G. Catto-Smith, Carlos H. Lifschitz
Publikováno v:
Acta Paediatrica (Oslo, Norway : 1992)
Aim Regurgitation, infantile colic and functional constipation are common functional gastrointestinal disorders (FGIDs) during infancy. Our aim was to carry out a concise review of the literature, evaluate the impact of these common FGIDs on infants
Publikováno v:
Pharmaceuticals
Volume 6
Issue 10
Pages 1322-1334
Pharmaceuticals, Vol 6, Iss 10, Pp 1322-1334 (2013)
Volume 6
Issue 10
Pages 1322-1334
Pharmaceuticals, Vol 6, Iss 10, Pp 1322-1334 (2013)
Secondary loss of response (LoR) often precludes further use of infliximab in children with Crohn’s disease. Immunomodulators may reduce the incidence of LoR but their combination with infliximab presents safety concerns. We aimed to determine the
Autor:
Tianhong Wu, Anthony G. Catto-Smith
Publikováno v:
Constipation: Current & Emerging Treatments. :190-207